Product Information

MEMANTINE-DONEPEZIL ER 14-10 MG is a generic product labeled by Vitruvias Therapeutics Inc., priced at $9.6967 per EA under NDC 69680018330. Its NADAC has been published 42 times since Sep 10, 2025.

MEMANTINE-DONEPEZIL ER 14-10 MG

memantine hydrochloride and donepezil hydrochloride
$9.6967per EA

Strength

10; 14 mg/1; mg/1

NDC

69680018330

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA216901

On Market Since

7/16/2025

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors
N-methyl-D-aspartate Receptor Antagonist
NMDA Receptor Antagonists

Price Statistics

The NADAC for MEMANTINE-DONEPEZIL ER 14-10 MG has been published 42 times since Sep 10, 2025, and over the history we have for it it has declined 40.3%. The table below summarizes its recorded NADAC range and movement.

Current price$9.6967 per EA
All-time high$16.2469 (Sep 10, 2025)
All-time low$9.6967 (Jun 17, 2026)
52-week high$16.2469
52-week low$9.6967
Median price$14.0508
Average price$13.3399
Largest weekly change-10.9% (Apr 22, 2026)
Weeks tracked42
Tracking sinceSep 10, 2025

Price History

1W

0.0%

1M

-3.5%

3M

-18.2%

6M

-34.7%

1Y

N/A

3Y

N/A

5Y

N/A

All

-40.3%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of MEMANTINE-DONEPEZIL ER 14-10 MG?

The current National Average Drug Acquisition Cost (NADAC) for MEMANTINE-DONEPEZIL ER 14-10 MG, manufactured by Vitruvias Therapeutics Inc., is $9.6967 per EA (NDC 69680018330), effective Jun 24, 2026.

How has the price of MEMANTINE-DONEPEZIL ER 14-10 MG changed over time?

Over the history we have for it, the NADAC for MEMANTINE-DONEPEZIL ER 14-10 MG has declined 40.3%. It has been tracked across 42 weekly CMS publications since Sep 10, 2025.

What are the highest and lowest recorded NADAC prices for MEMANTINE-DONEPEZIL ER 14-10 MG?

Since Sep 10, 2025, the NADAC for MEMANTINE-DONEPEZIL ER 14-10 MG has ranged from a low of $9.6967 (Jun 17, 2026) to a high of $16.2469 (Sep 10, 2025), with a median of $14.0508 per EA.

Are there cheaper alternatives to MEMANTINE-DONEPEZIL ER 14-10 MG?

1 NADAC-published product shares the same active ingredient, strength, and dosage form as MEMANTINE-DONEPEZIL ER 14-10 MG, but none are currently priced below it.

Who manufactures MEMANTINE-DONEPEZIL ER 14-10 MG?

MEMANTINE-DONEPEZIL ER 14-10 MG (NDC 69680018330) is labeled by Vitruvias Therapeutics Inc., and CMS classifies it as a generic product.